Align Technology | ALGN - Cash And Equivalent


Align Technology reported $1B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
3M USD 5.24B 564M Dec/2025
Align Technology USD 1B 103.43M Sep/2025
Becton, Dickinson and Co. USD 740M 99M Dec/2025
Bruker USD 293.1M 201.1M Sep/2025
Cardinal Health USD 2.78B 1.82B Dec/2025
Charles River Laboratories USD 213.77M 6.67M Dec/2025
Cooper Companies USD 124.9M 13.3M Jun/2025
CVS Health USD 8.45B 645M Dec/2025
Danaher USD 4.62B 3.09B Dec/2025
Dentsply International USD 363M 4M Sep/2025
Dexcom USD 917.7M 918M Dec/2025
Henry Schein USD 136M 9M Sep/2025
Idexx Laboratories USD 180.07M 28.1M Dec/2025
Insulet USD 716.1M 41.3M Dec/2025
Integra LifeSciences USD 235.05M 2.86M Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Masimo USD 312.3M 162.7M Sep/2025
McKesson USD 2.96B 1.05B Dec/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Revvity USD 919.86M 11.53M Dec/2025
Solventum Corp USD 1.64B 1.15B Sep/2025
Stryker USD 4.01B 755M Dec/2025
Teleflex USD 354M 100.3M Sep/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Veeva Systems USD 1.66B 270.29M Sep/2025
Waters USD 587.83M 128.71M Dec/2025
Zimmer Biomet Holdings USD 591.9M 700.8M Dec/2025
Zoetis USD 2.08B 649M Sep/2025